DekaBank Deutsche Girozentrale - RAPT THERAPEUTICS INC ownership

RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 111 filers reported holding RAPT THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.9%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of RAPT THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$152
-10.1%
9,0000.0%0.00%
Q4 2022$169
-99.9%
9,0000.0%0.00%
-100.0%
Q3 2022$217,000
+32.3%
9,0000.0%0.00%
Q2 2022$164,000
-16.3%
9,0000.0%0.00%
Q1 2022$196,000
-32.9%
9,000
+9.8%
0.00%
-100.0%
Q4 2021$292,000
+15.0%
8,200
+2.5%
0.00%0.0%
Q3 2021$254,000
-2.3%
8,0000.0%0.00%0.0%
Q2 2021$260,000
+51.2%
8,0000.0%0.00%0.0%
Q1 2021$172,000
+9.6%
8,0000.0%0.00%0.0%
Q4 2020$157,0008,0000.00%
Other shareholders
RAPT THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Column Group LLC 2,680,621$53,076,29617.67%
Euclidean Capital LLC 432,900$8,571,4208.02%
GREAT POINT PARTNERS LLC 1,436,569$28,444,0665.58%
KINGDON CAPITAL MANAGEMENT, L.L.C. 880,000$17,424,0003.47%
Trustees of Columbia University in the City of New York 73,383$1,4533.00%
Cheyne Capital Management (UK) LLP 71,828$1,422,1942.48%
Deep Track Capital, LP 1,304,940$25,837,8121.08%
Ghost Tree Capital, LLC 125,000$2,475,0001.06%
Perceptive Advisors 1,798,955$35,619,3091.00%
BRAIDWELL LP 1,000,000$19,800,0000.66%
View complete list of RAPT THERAPEUTICS INC shareholders